Skip to content
Screener

Madrigal Pharmaceuticals, Inc. MDGL Gross margin

Gross margin at other companies

Eli Lilly logo
Eli LillyLLY
83.4%+0.8pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
95.1%-1.1pp
Delcath Systems logo
Delcath SystemsDCTH
87.1%+1.2pp
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
93.4%+3.7pp

Other financials

Income statement

See full
Revenue$364.3M+71.2%
Gross profit$43.5M—
Operating income-$56.3M-19.3%
Net income-$57.9M-37.0%
EPS (diluted)-$1.99-4.7%

Balance sheet

See full
Cash & equivalents$292.9M+53.2%
Total debt$377.9M+179%
Total equity$523.7M-24.7%
Total assets$1.2B+22.6%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$4.3M—
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.88B+57.6%
Enterprise value$11.96B+59.9%
P/S9.3×-5.4×

Profitability

See full
Operating margin-25.1%-9.2pp
Net margin-25.3%-8.8pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-53.3%+47.0pp
Debt / equity0.7×+0.5×
Current ratio3.2×-1.9×

Where this comes from

Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.

gross profit/total revenue=96.5%

Based on trailing twelve months.

The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 9:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050845

FAQ

What is Madrigal Pharmaceuticals, Inc.'s gross margin?
Madrigal Pharmaceuticals, Inc. (MDGL) reported gross margin of 96.5% in Q4 2024.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.

Ask your AI about Madrigal Pharmaceuticals, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude